Public Profile

ProPhase Labs, Inc.

ProPhase Labs, Inc., headquartered in the United States, is a prominent player in the health and wellness industry, specialising in dietary supplements and over-the-counter products. Founded in 1996, the company has achieved significant milestones, including the development of innovative health solutions that cater to a diverse consumer base. With a focus on quality and efficacy, ProPhase Labs offers a range of unique products, including immune support supplements and cold relief formulations. Their commitment to rigorous testing and high manufacturing standards sets them apart in a competitive market. Recognised for their dedication to health and wellness, ProPhase Labs continues to strengthen its position as a trusted name in the industry, serving customers across major operational regions in North America.

DitchCarbon Score

How does ProPhase Labs, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

ProPhase Labs, Inc.'s score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

ProPhase Labs, Inc.'s reported carbon emissions

ProPhase Labs, Inc., headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives related to climate commitments. Without specific emissions figures or defined goals, it is challenging to assess their environmental impact or progress in reducing carbon emissions. The company may still be in the process of developing its climate strategy or reporting framework. As the industry increasingly prioritises sustainability, ProPhase Labs may consider establishing measurable targets to align with global climate commitments and enhance its environmental stewardship.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ProPhase Labs, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ProPhase Labs, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ProPhase Labs, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Labcorp

US
Health and social work services (85)
Updated 3 days ago

Interpace Biosciences, Inc.

US
Other business services (74)
Updated 3 days ago

Quest Diagnostics

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers